A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
N Engl J Med
.
2020 Jul 9;383(2):e8.
doi: 10.1056/NEJMc2017351.
Authors
Kazuyuki Yahagi
1
,
Yu Sato
2
,
Renu Virmani
2
Affiliations
1
Mitsui Memorial Hospital, Tokyo, Japan.
2
CVPath Institute, Gaithersburg, MD rvirmani@cvpath.org.
PMID:
32640142
DOI:
10.1056/NEJMc2017351
No abstract available
Publication types
Letter
Comment
MeSH terms
Aortic Valve Stenosis / surgery*
Heart Valve Prosthesis*
Humans
Rivaroxaban
Transcatheter Aortic Valve Replacement*
Substances
Rivaroxaban